Pipobroman
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one | |
| Clinical data | |
| Trade names | Vercite, Vercyte |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 54-91-1 |
| ATC code | L01AX02 |
| PubChem | CID 4842 |
| DrugBank | DB00236 |
| ChemSpider | 4676  |
| UNII | 6Q99RDT97R |
| KEGG | D00467 |
| ChEMBL | CHEMBL1585 |
| Chemical data | |
| Formula | C10H16Br2N2O2 |
| Mol. mass | 356.054 g/mol |
|
|
|
|
 (what is this?) (verify) |
|
Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.[1] It is marketed by Abbott Laboratories.[2]
References[edit]
- ^ Passamonti, F.; Lazzarino, M. (2003). "Treatment of Polycythemia Vera and Essential Thrombocythemia: The Role of Pipobroman". Leukemia & Lymphoma 44 (9): 1483–1488. doi:10.3109/10428190309178768. PMID 14565648.
- ^ Drugs.com: Pipobroman
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
